close

A A A
Menu

National Adult Vaccination Program

Article Index

NAVP Logo

GSA is dedicated to bringing the diverse interdisciplinary team together to increase reverence for vaccines.

In 2010, GSA established the National Adult Vaccination Program to improve adult immunization rates. During the past decade, GSA has convened and collaborated with the multidisciplinary stakeholder community to raise awareness of the natural immunosenescence that occurs as we age; advocating for policies that are favorable to the access of vaccines; and training champions to stimulate vaccination policies and rates.

In 2022, our objective is to Catalyze The Diverse Multidisciplinary Team To Champion Vaccination.

NAVP will:

  • Convene multidisciplinary experts annually to address current vaccine issues for older adults and
    identify sustainable solutions
  • Disseminate current insights and implications from therapeutic advances and enhanced delivery
    of vaccines
  • Advocate for policies that improve adult vaccination rates

The GSA NAVP is guided by a group of vaccine and policy experts that provide strategic recommendations and direction:

douglas

R. Gordon Douglas, MD (Chair)
Professor Emeritus of Medicine
Weill Cornell Medical College

gravenstein

Stefan Gravenstein, MD, FGSA
David S. Greer Professor of Geriatric Medicine
Director, Division of Geriatrics and Palliative Care
Brown University Schools of Medicine and Public Health

cantu

Michelle Cantu, MPH
Senior Director, Immunization & MCAH
National Association of County and City Health Officials

resnick

Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, FGSA
Sonya Ziporkin Gershowitz Chair in Gerontology
University of Maryland

dcasanova

Danielle Casanova, MBA
Senior Director, Population Health Initiatives
American Medical Group Foundation

schaffner

William Schaffner, MD
Professor of Preventive Medicine in the Department of Health Policy
Professor of Medicine in the Division of Infectious Diseases
Vanderbilt University School of Medicine

 

NAVP is developed by The Gerontological Society of America and supported by:

glaxosmithklineJohnson & Johnson Health Care Systems   merckpfizer   Sanofi PasteurSeqirus

Share This Page!

Print Page